|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
90,552,000 |
Market
Cap: |
3.31(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.07 - $44.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8 |
Insider 3/6 Months : 8.6 |
|
Guru Rank Number : 538 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
7,700 |
7,700 |
7,700 |
Total Buy Value |
$0 |
$198,736 |
$198,736 |
$198,736 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
26,156 |
72,347 |
84,013 |
300,515 |
Total Sell Value |
$921,768 |
$2,218,045 |
$2,683,017 |
$13,658,321 |
Total People Sold |
4 |
9 |
10 |
16 |
Total Sell Transactions |
6 |
28 |
29 |
90 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-10-06 |
4 |
OE |
$10.85 |
$1,368,902 |
D/D |
124,351 |
107,910 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-10-06 |
4 |
AS |
$50.08 |
$125,208 |
D/D |
(2,500) |
9,562 |
|
20% |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-10-06 |
4 |
OE |
$18.01 |
$45,025 |
D/D |
2,500 |
12,062 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-10-05 |
4 |
AS |
$50.00 |
$2,773,000 |
D/D |
(55,460) |
56,085 |
|
21% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-10-05 |
4 |
OE |
$10.85 |
$601,741 |
D/D |
55,460 |
110,645 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-10-05 |
4 |
AS |
$48.68 |
$38,311 |
D/D |
(787) |
9,562 |
|
21% |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-10-05 |
4 |
OE |
$11.23 |
$8,838 |
D/D |
787 |
10,349 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-07-15 |
4 |
AS |
$55.48 |
$5,570,151 |
D/D |
(100,000) |
56,085 |
|
14% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-07-15 |
4 |
OE |
$10.85 |
$1,085,000 |
D/D |
100,000 |
106,085 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2020-07-07 |
4 |
AS |
$54.11 |
$1,688,037 |
D/D |
(30,625) |
39,724 |
|
11% |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2020-07-07 |
4 |
OE |
$11.23 |
$462,569 |
D/D |
30,625 |
57,224 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-07-06 |
4 |
AS |
$52.98 |
$176,564 |
D/D |
(3,288) |
9,562 |
|
11% |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-07-06 |
4 |
OE |
$11.23 |
$53,874 |
D/D |
3,288 |
12,062 |
|
- |
|
Hill Emily Luisa |
Chief Financial Officer |
|
2020-06-29 |
4 |
AS |
$52.50 |
$135,503 |
D/D |
(2,581) |
13,610 |
|
17% |
|
Graham Dawn |
Director |
|
2020-06-11 |
4 |
S |
$48.36 |
$17,603 |
D/D |
(364) |
26,286 |
|
-8% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-20 |
4 |
AS |
$50.00 |
$1,689,400 |
D/D |
(33,788) |
56,085 |
|
-2% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-20 |
4 |
OE |
$10.85 |
$366,600 |
D/D |
33,788 |
89,873 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-18 |
4 |
AS |
$50.12 |
$314,979 |
D/D |
(6,284) |
56,085 |
|
5% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-18 |
4 |
OE |
$10.85 |
$68,181 |
D/D |
6,284 |
62,369 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-05 |
4 |
AS |
$50.33 |
$5,533,592 |
D/D |
(109,928) |
56,085 |
|
-1% |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2020-05-05 |
4 |
OE |
$10.85 |
$1,192,719 |
D/D |
109,928 |
166,013 |
|
- |
|
Jacobson Allan Steven |
Director |
|
2020-04-20 |
4 |
AS |
$50.58 |
$913,558 |
D/D |
(17,900) |
8,498 |
|
-5% |
|
Jacobson Allan Steven |
Director |
|
2020-04-20 |
4 |
OE |
$10.85 |
$194,215 |
D/D |
17,900 |
26,398 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-04-17 |
4 |
AS |
$50.00 |
$107,250 |
D/D |
(2,145) |
9,304 |
|
-3% |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2020-04-17 |
4 |
OE |
$18.01 |
$38,631 |
D/D |
2,145 |
11,449 |
|
- |
|
568 Records found
|
|
Page 13 of 23 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|